Effect of route of administration on the pharmacokinetics of etretinate in the dog.
作者信息
Bornemann L D, Cotler S, Khoo K C, Carbone J J, Colburn W A
机构信息
Department of Clinical Research and Development, Hoffmann-La Roche Inc., Nutley, N.J. 07110.
出版信息
Biopharm Drug Dispos. 1988 Jan-Feb;9(1):119-26. doi: 10.1002/bod.2510090112.
PMID:2963666
Abstract
摘要
相似文献
1
Effect of route of administration on the pharmacokinetics of etretinate in the dog.给药途径对维甲酸在犬体内药代动力学的影响。
Biopharm Drug Dispos. 1988 Jan-Feb;9(1):119-26. doi: 10.1002/bod.2510090112.
2
The pharmacokinetics of etretinate and its metabolites in the dog.依曲替酯及其代谢产物在犬体内的药代动力学。
Drug Metab Dispos. 1989 Sep-Oct;17(5):473-80.
3
Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.银屑病治疗期间阿维A酯及其主要代谢物的血浆和抽吸水疱液水平
Arch Dermatol Res. 1982;272(1-2):147-9. doi: 10.1007/BF00510406.
4
Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
Drug Metab Dispos. 1989 Nov-Dec;17(6):652-5.
5
UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.紫外线诱导的口服类视黄醇在体外及无毛小鼠体内的异构化
Photodermatol Photoimmunol Photomed. 1990 Aug;7(4):146-52.
6
Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.依曲替酯在患有肝纤维化的银屑病患者中的药代动力学。
Pharmacol Toxicol. 1989 Nov;65(5):393-7. doi: 10.1111/j.1600-0773.1989.tb01196.x.
7
Persistent etretinate levels in plasma after changing the therapy to acitretin.
Arch Dermatol Res. 1990;282(5):343-4. doi: 10.1007/BF00375730.
8
9
Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.阿维A与依曲替酯治疗重度银屑病的疗效比较。一项针对168例患者的双盲随机北欧多中心研究。
Acta Derm Venereol Suppl (Stockh). 1989;146:206-7.
10
Pharmacokinetics and drug interactions of etretinate and acitretin.依曲替酯和阿维A的药代动力学及药物相互作用
J Am Acad Dermatol. 1992 Dec;27(6 Pt 2):S19-22. doi: 10.1016/s0190-9622(08)80255-1.
Zotero 插件